Skip to content
Unrated Drug recall · FDA · Published March 27, 2023

Teva Montelukast Sodium Oral Granules 4mg Recall: Failed Impurities Risk

Teva recalls Montelukast Sodium Oral Granules 4mg (30-pack) due to failed impurities. This may pose health risks. Contact Teva for details.

🇺🇸 FDA recall #D-0510-2023DrugTeva ›
Take action

Contact the company

Recalling firmTeva Pharmaceuticals USA Inc400 Interpace Pkwy Bldg A · Parsippany, NJ 07054-1120
✎ GovInfoNow plain-language explainer

Teva is recalling Montelukast Sodium Oral Granules 4mg (30-pack) because impurities in the product could be harmful. This is a prescription-only medication that may pose health risks if used. Read more at govinfonow.com/recall/33750-teva-montelukast-sodium-oral-granules-4mg-recall-failed-impurities-risk.

Source Summary by GovInfoNow · govinfonow.com/recall/33750-teva-montelukast-sodium-oral-granules-4mg-recall-failed-impurities-risk · Updated August 17, 2026 · FDA enforcement record: FDA #D-0510-2023

Cite this page

“Teva Montelukast Sodium Oral Granules 4mg Recall: Failed Impurities Risk.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/33750-teva-montelukast-sodium-oral-granules-4mg-recall-failed-impurities-risk. Based on FDA recall #D-0510-2023 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0510-2023%22&limit=1).

The FDA announced on March 27, 2023, that Teva Pharmaceuticals USA Inc. is recalling Montelukast Sodium Oral Granules USP, 4 mg, due to failed impurity specifications. The recall affects 3,772 cartons distributed nationwide.

How to tell if you have it

  • Brand: Teva
  • Product: Montelukast Sodium Oral Granules USP, 4 mg
  • Packaging: Carton containing 30 packets
  • Carton NDC: 0093-7487-56
  • Packet NDC: 0093-7487-19
  • Lot #: 3007556A
  • Expiration Date: 5/2023
  • Quantity: 3,772 cartons

The hazard

The product failed impurities for Sulphoxide and Impurity A. The FDA classified this as a Class III recall.

Context

GovInfoNow's records show Teva Pharmaceuticals USA, Inc. has 59 other recalls on record since April 2, 2012. Other recent recalls of similar products include Teva recalling traZODone 50mg tablets on August 24, 2026, and Teva Octreotide Acetate 30mg Kit on April 24, 2026. Recent industry recalls also include Sagent Busulfan Injection on May 4, 2026, QuVa Pharma Methohexital Sodium on June 24, 2026, and OneSource Specialty Pharma Methohexital Sodium on June 7, 2026.

How to tell if you have this one

Check for the carton NDC 0093-7487-56 and packet NDC 0093-7487-19. Look for lot number 3007556A with expiration date 5/2023.

  • Brand
    Teva
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Product Details

    Verify the carton NDC 0093-7487-56, packet NDC 0093-7487-19, and lot number 3007556A.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “USA Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 5 months after the firm started it.

1. Firm started the recall: Mar 27, 202312. FDA classified it Class III: Apr 6, 202323. Published in FDA’s Enforcement Report: Apr 12, 202334. FDA terminated the recall: Aug 23, 202342023
  1. Firm started the recall
  2. FDA classified it Class III
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Other Teva recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0510-2023 (March 27, 2023) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0510-2023 to see it in context.
  • Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA